The 10 new flu-related deaths in children bring the season's total to 226, the most since 2009-10.
The loss of activity is equivalent to 15% of the US population becoming completely immobile for 1 day.
Adult COVID-19 patients also infected with the flu are 4 times more likely to need mechanical ventilation and 2.4 times more likely to die.
The roadmap offers a powerful opportunity to leverage advances in vaccine science to better protect against influenza, including pandemic flu.
The Influenza Vaccines Roadmaps Initiative newsletter highlights recent news, research, and events pertaining to influenza vaccine R&D.
A database of novel vaccine candidates that are designed to provide broader and more durable protection against influenza viruses.
Help support our work on influenza. Advance the work of CIDRAP in public health preparedness and emerging infectious disease response.
Receive the latest infectious disease information.
Today the US Food and Drug Administration (FDA) approved Xofluza (baloxavir marboxil) for the treatment of flu in patients ages 12 years and older who have been symptomatic for no more than 48 hours.
Xofluza is the first novel flu treatment approved by the FDA in nearly 20 years; the FDA approved the neuraminidase inhibitors oseltamivir and zanamivir in 1999.
The CDC started its reporting for the new flu season last week, and so far most of the United States is experiencing sporadic flu detections.
The Centers for Disease Control and Prevention (CDC) today announced a new outbreak of multidrug-resistant Salmonella Infantis infections tied to raw chicken products.
Late yesterday afternoon and today the Democratic Republic of the Congo (DRC) announced five more cases of Ebola virus disease in Beni and Butembo, the current epicenter of outbreak activity.
All three cases announced yesterday resulted in community deaths that involved safe and dignified burials in Beni, the country's health ministry said. Today two cases, one each in Beni and Butembo, were reported.
The Saudi Arabian Ministry of Health (MOH) today recorded a new case of MERS-CoV for epidemiologic week 40, which is this week.
A 49-year-old man from Najran was diagnosed as having MERS-CoV (Middle East respiratory syndrome coronavirus). The MOH said the man was hospitalized and likely exposed to the virus in a community setting. He had not reported recent contact with camels, a known risk factor.
As the Southern Hemisphere's flu season winds down, disease levels in temperate South American and southern Africa countries decreased or have peaked in recent weeks, according to the latest global flu update from the World Health Organization (WHO).
Coverage in kids 4 and younger was 67.8% last season, down 2.2 percentage points.
The US Food and Drug Administration (FDA) today released new draft guidance that spells out when it's appropriate to disclose retail information for recalled products.
As the number of Ebola cases and deaths held steady in the Democratic Republic of the Congo (DRC) over the last 2 days, the number of people vaccinated passed the 10,000 mark.
Passengers and crew on two inbound flights to Philadelphia yesterday were held for medical evaluation after some passengers were sick with flulike symptoms, the airport said yesterday in a statement.
